Cargando…
Dose-related and contextual aspects of suboptimal adherence to antiretroviral therapy among persons living with HIV in Western Europe
BACKGROUND: The daily oral dosing requirement for antiretroviral therapy (ART) may be challenging for some people living with HIV (PLWHIV) with comorbid conditions, confidentiality concerns or pill fatigue. We investigated suboptimal adherence from the perspective of PLWHIV and HIV physicians. METHO...
Autores principales: | Akinwunmi, Babatunde, Buchenberger, Daniel, Scherzer, Jenny, Bode, Martina, Rizzini, Paolo, Vecchio, Fabio, Roustand, Laetitia, Nachbaur, Gaelle, Finkielsztejn, Laurent, Chounta, Vasiliki, Van de Velde, Nicolas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8277220/ https://www.ncbi.nlm.nih.gov/pubmed/33462616 http://dx.doi.org/10.1093/eurpub/ckaa229 |
Ejemplares similares
-
Costs and mortality associated with HIV: a machine learning analysis of the French national health insurance database
por: Prodel, Martin, et al.
Publicado: (2021) -
Patient preferences and health state utilities associated with the treatment process of antiretroviral therapy for people living with HIV
por: Matza, Louis S., et al.
Publicado: (2022) -
Indirect comparison of 48-week efficacy and safety of long-acting cabotegravir and rilpivirine maintenance every 8 weeks with daily oral standard of care antiretroviral therapy in participants with virologically suppressed HIV-1-infection
por: Chounta, Vasiliki, et al.
Publicado: (2022) -
2496. Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Daily Oral and Long-Acting Injectable Antiretroviral Treatment among People Living with HIV
por: Matza, Louis S, et al.
Publicado: (2019) -
Qualitative Thematic Analysis of Social Media Data to Assess Perceptions of Route of Administration for Antiretroviral Treatment among People Living with HIV
por: Matza, Louis S., et al.
Publicado: (2020)